Kaufman Rossin Wealth LLC Takes Position in Humana Inc. $HUM

Key Points

• Kaufman Rossin Wealth LLC has acquired a new position in Humana Inc., purchasing 1,794 shares valued at approximately $475,000.
• Institutional investors own a significant portion of Humana, with 92.38% of the company's stock held by them, including significant increases from firms like Vanguard Group and GAMMA Investing LLC.
• Humana's most recent quarterly earnings report indicates earnings per share of $6.27, which missed expectations, while revenue increased by 9.6% year-over-year to $32.39 billion.

Kaufman Rossin Wealth LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,794 shares of the insurance provider's stock, valued at approximately $475,000.

Several other large investors have also recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC lifted its position in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after acquiring an additional 46 shares during the last quarter. Applied Finance Capital Management LLC boosted its stake in shares of Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after buying an additional 48 shares during the period. Achmea Investment Management B.V. boosted its stake in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock valued at $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. increased its stake in Humana by 6.1% in the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after acquiring an additional 50 shares during the last quarter. Finally, Townsquare Capital LLC increased its stake in Humana by 2.8% in the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock valued at $597,000 after acquiring an additional 61 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Trading Down 0.6%

HUM stock traded down $1.73 during midday trading on Monday, hitting $297.78. The stock had a trading volume of 873,682 shares, compared to its average volume of 1,722,239. The firm has a market cap of $35.81 billion, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 1.76 and a beta of 0.44. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $382.72. The business has a fifty day moving average price of $248.58 and a two-hundred day moving average price of $253.29.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana's payout ratio is presently 27.17%.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Royal Bank Of Canada boosted their target price on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research note on Thursday. Truist Financial cut their price target on Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Robert W. Baird cut their price target on Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Finally, Bank of America cut their price target on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company's stock. According to MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average price target of $283.29.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.